LAUREN MURCHISON: Open Payments
NPI 1245087923 · RUSSELLVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $142 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $173 |
| ABBVIE INC. | 2 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Amgen Inc. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: SPRAVATO, VRAYLAR, CAPLYTA, BREZTRI, Auvelity, OTEZLA, GVOKE HYPOPEN, MOUNJARO.
Industry payments across AR — which companies pay providers there.
